Notice of passing of CanCURE Team member Dr. Mark Wainberg

April 13, 2017

CanCURE would like to extend its deepest condolences to the family, friends and colleagues of CanCURE Team member Dr. Mark Wainberg who suddenly passed away this week in Bal Harbour, Florida. Dr. Wainberg’s several contributions in the fight against HIV has been more than monumental since the very beginning of the pandemic, including the initial identification of the 3TC antiretroviral drug, which allowed to save the lives of millions of individuals throughout the world. Dr. Wainberg was the Head of AIDS research at the Lady Davis Institute for Medical Research at the Jewish General Hospital in Montreal, Director of the McGill University AIDS Centre, and Professor of Medicine and of Microbiology and Immunology. Dr. Wainberg was a Fellow of the Royal Society of Canada, an Officer of the Order of Canada, an Officer of the Ordre National du Québec, an Honorary Fellow of the Royal College of Physicians and Surgeons of Canada, and a Chevalier in the Légion d’Honneur of France. He was recently appointed to the Canadian Medical Hall of Fame in recognition of having “revolutionized our understanding of HIV/AIDS at medical, epidemiological and political levels.”


Read more on Dr. Wainberg's career and contributions >>

Tribute to Mark published in Retrovirology >>

Dr. Mark Wainberg (photo: Université McGill)


Please reload

Les membres de CanCURE se réunissent virtuellement pour la 6e assemblée générale annuelle

November 24, 2020

CanCURE members reunite virtually for the 6th Annual General Meeting

November 24, 2020

Félicitations aux laboratoires Chomont et Routy pour leur publication dans Nature Communications!

August 17, 2020

Please reload

©2019 CanCURE


  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon